Cilostazol for treating nonalcoholic fatty liver disease
Treatments studied
Part of Digestive system clinical trials.
This study tests whether a medicine called cilostazol can help treat nonalcoholic fatty liver disease. It is for adults who have fatty liver seen on an ultrasound and do not have other liver problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been told you have fatty liver after an ultrasound scan of your belly
- You do not drink too much alcohol (more than 2 drinks a day for men, or 1.5 drinks a day for women)
- You do not have other liver diseases like hepatitis B, hepatitis C, or drug-induced liver injury
- You do not have chronic kidney disease, parathyroid problems, or congestive heart failure
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called erdosteine can help treat non-alcoholic fatty liver disease (a condition where extra fat builds up in the liver, not caused by alcohol). It is for adults who have fatty liver confirmed by ultrasound and who do not have other serious health problems.
This study tests whether intermittent fasting can improve fatty liver disease (NAFLD) by reducing liver fat. It focuses on adults with confirmed fatty liver and extra liver fat seen on a special MRI scan.
This study tests a medicine called carbocisteine to see if it can help treat nonalcoholic fatty liver disease (NAFLD). If you have a fatty liver and no other liver or kidney conditions, this trial may explore whether this drug is safe and effective for you.
This study tests whether a combination of rutin (a plant compound) and vitamin C can help people with fatty liver disease (MASLD). If you have MASLD and no other serious liver conditions, this trial may be a good fit.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
This study tests whether a new drug called AZD2389 is safe and well-tolerated in adults with steatotic liver disease (fatty liver) that has progressed to advanced scarring. The trial aims to see if this drug might help slow or improve liver damage in people with this condition.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.